Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related deaths
worldwide. HCC initiation, progression, and therapy failure are all influenced by various …

Background MicroRNA-155 has been discussed as a biomarker in cancer diagnosis and
prognosis. Although relevant studies have been published, the role of microRNA-155 …

MicroRNAs (miRNAs) can act as oncogenes or tumor suppressors, capable of up or down‐
regulating gene expression during tumorigenesis; they are diagnostic biomarkers or …

Background The hepatocellular carcinoma (HCC) incident rate is gradually increasing
yearly despite all the research and efforts taken by scientific communities and governing …

Currently, microRNAs have been established as central players in tumorigenesis, but above
all, they have opened an important door for our understanding of immune and tumor cell …

Extracellular vesicles (EVs), defined as intercellular messengers that carry their cargos
between cells, are involved in several physiological and pathological processes. These …

Hepatocellular carcinoma (HCC) is the main pathological type of liver cancer. Due to its
insidious onset and the lack of specific early markers, HCC is often diagnosed at an …

Cancer nanomedicine has been investigated widely and boomed in the last two decades,
resulting in designing nanostructures with biofunctionalization, giving rise to an “All-in-One” …

Diabetes mellitus (DM) has grown in attention in recent years as a result of its debilitating
complications and chronic disabilities. Diabetic retinopathy (DR) is a chronic microvascular …

Gastrointestinal (GI) cancers account for one-fourth of the global cancer incidence and are
incriminated to cause one-third of cancer-related deaths. GI cancer includes esophageal …